checkAd

     129  0 Kommentare Replimune Strengthens Executive Team with the Appointment of Jean Franchi as Chief Financial Officer - Seite 3

    Investor Inquiries
    Chris Brinzey
    Westwicke, an ICR Company
    339.970.2843
    chris.brinzey@westwicke.com

    Lesen Sie auch

    Media Inquiries
    Arleen Goldenberg
    Verge Scientific Communications
    917.548.1582
    agoldenberg@vergescientific.com


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Replimune Strengthens Executive Team with the Appointment of Jean Franchi as Chief Financial Officer - Seite 3 WOBURN, Mass., Dec. 09, 2019 (GLOBE NEWSWIRE) - Replimune Group Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, today announced the expansion of its executive team with …